Teva wins Canadian Viagra row
This article was originally published in Scrip
Executive Summary
Teva can now start marketing generic versions of Pfizer's erectile dysfunction drug Viagra (sildenafil) in Canada. The Supreme Court there yesterday backed Teva's challenge to the drug's patent, which was due to expire in 2014.